Literature DB >> 6225577

The immune system in familial Mediterranean fever.

I Melamed, Y Shemer, V Zakuth, E Tzehoval, M Pras, Z Spirer.   

Abstract

Familial Mediterranean fever (FMF) is a genetic disorder with an obscure aetiology. In attempts to investigate a possible immunoregulatory imbalance involved in this disease we tested 24 FMF patients for suppressor T cell activity and for chemotaxis of mononuclear cells. The suppressor T cell activity and chemotaxis were decreased in untreated FMF patients as compared to colchicine treated patients or normal controls. Amyloid FMF patients manifested significantly increased chemotactic activity, while the suppressor T cell activity was normal. This finding may extend our knowledge concerning the immune mechanism involved in FMF.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6225577      PMCID: PMC1535657     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  Letter: Colchicine in familial Mediterranean fever.

Authors:  D Zemer; M Pras; E Sohar; J Gafni
Journal:  N Engl J Med       Date:  1976-01-15       Impact factor: 91.245

2.  Monocyte function in familial Mediterranean fever.

Authors:  M Bar-Eli; R Gallily; M Levy; M Eliakim
Journal:  Am J Med Sci       Date:  1977 Nov-Dec       Impact factor: 2.378

3.  Colchicine therapy for familial mediterranean fever. A double-blind trial.

Authors:  C A Dinarello; S M Wolff; S E Goldfinger; D C Dale; D W Alling
Journal:  N Engl J Med       Date:  1974-10-31       Impact factor: 91.245

4.  A controlled trial of colchicine in preventing attacks of familial mediterranean fever.

Authors:  D Zemer; M Revach; M Pras; B Modan; S Schor; E Sohar; J Gafni
Journal:  N Engl J Med       Date:  1974-10-31       Impact factor: 91.245

Review 5.  Familial Mediterranean fever. A survey of 470 cases and review of the literature.

Authors:  E Sohar; J Gafni; M Pras; H Heller
Journal:  Am J Med       Date:  1967-08       Impact factor: 4.965

6.  Immunoregulatory abnormalities in familial Mediterranean fever.

Authors:  D Ilfeld; S Weil; O Kuperman
Journal:  Clin Immunol Immunopathol       Date:  1981-02

Review 7.  Molecular and cellular mechanisms of leukocyte chemotaxis.

Authors:  R Snyderman; E J Goetzl
Journal:  Science       Date:  1981-08-21       Impact factor: 47.728

8.  Effect of prophylactic colchicine therapy on leukocyte function in patients with familial Mediterranean fever.

Authors:  C A Dinarello; M J Chusid; A S Fauci; J I Gallin; D C Dale; S M Wolff
Journal:  Arthritis Rheum       Date:  1976 May-Jun

9.  Incidence of amyloidosis in recurrent polyserositis (familial Mediterranean fever).

Authors:  M Eliakim
Journal:  Isr J Med Sci       Date:  1970 Jan-Feb

10.  Leukocyte function in familial Mediterranean fever.

Authors:  M C Territo; R S Peters; M J Cline
Journal:  Am J Hematol       Date:  1976       Impact factor: 10.047

  10 in total
  2 in total

1.  Effect of colchicine on T cell subsets of healthy volunteers.

Authors:  D Ilfeld; E Feierman; O Kuperman; S Kivity; M Topilsky; L Netzer; M Pecht; N Trainin
Journal:  Immunology       Date:  1984-11       Impact factor: 7.397

2.  Serum concentration and urinary excretion of beta 2-microglobulin and microalbuminuria in familial Mediterranean fever.

Authors:  U Saatci; S Ozdemir; S Ozen; A Bakkaloglu
Journal:  Arch Dis Child       Date:  1994-01       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.